نتائج البحث - Pratima Chowdary

تنقيح النتائج
  1. 1
    Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab

    Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab حسب Pratima Chowdary

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia

    Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia حسب Pratima Chowdary

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Current and emerging gene therapies for haemophilia A and B

    Current and emerging gene therapies for haemophilia A and B حسب Radosław Kaczmarek, Wolfgang Miesbach, Margareth C. Ozelo, Pratima Chowdary

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

    Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19 حسب Claire S. Whyte, Gael B. Morrow, Joanne Mitchell, Pratima Chowdary, Nicola J. Mutch

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?

    Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? حسب Francesco Violi, Stefania Basili, Valeria Raparelli, Pratima Chowdary, Alfred Gatt, A K Burroughs

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Hemostasis in patients with acute kidney injury secondary to acute liver failure

    Hemostasis in patients with acute kidney injury secondary to acute liver failure حسب Banwari Agarwal, Alex Gatt, Anne Riddell, Gavin Wright, Pratima Chowdary, Rajiv Jalan, Andrew K. Burroughs, Andrew Davenport

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline

    Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline حسب Elaine Gray, Steve Kitchen, Annette Bowyer, Pratima Chowdary, P. Vincent Jenkins, Paul Murphy, Sean Platton, Anne Riddell, Will Lester

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Alterations in coagulation following major liver resection

    Alterations in coagulation following major liver resection حسب Susan Mallett, Anita Sugavanam, Dominik Krzanicki, Selina Patel, R. Broomhead, Brian R Davidson, Anne Riddell, A. Gatt, Pratima Chowdary

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

    A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A حسب Hermann Eichler, Pantep Angchaisuksiri, Kaan Kavaklı, Paul Knoebl, Jerzy Windyga, Víctor Jiménez‐Yuste, A. Hyseni, Ute Friedrich, Pratima Chowdary

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    The use of enhanced half‐life coagulation factor concentrates in routine clinical practice: guidance from <scp>UKHCDO</scp>

    The use of enhanced half‐life coagulation factor concentrates in routine clinical practice: guidance from <scp>UKHCDO</scp> حسب Peter W. Collins, Elizabeth Chalmers, Pratima Chowdary, David Keeling, Mary Mathias, James S. O’Donnell, John Pasi, Savita Rangarajan, Abraham Thomas

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Prothrombin Complex Concentrates for Coagulopathy in Liver Disease: Single‐Center, Clinical Experience in 105 Patients

    Prothrombin Complex Concentrates for Coagulopathy in Liver Disease: Single‐Center, Clinical Experience in 105 Patients حسب Anja Drebes, M. De Vos, Sunita Gill, Emma Fosbury, Susan Mallett, Andy K. Burroughs, Banwari Agarwal, David Patch, Pratima Chowdary

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC

    Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC حسب Wolfgang Miesbach, Pratima Chowdary, Michiel Coppens, Daniel P. Hart, Víctor Jiménez‐Yuste, Robert Klamroth, Michael Makris, Declan Noone, Flora Peyvandi

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline

    Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline حسب P. Vincent Jenkins, Annette Bowyer, C.M. Burgess, Elaine Gray, Steve Kitchen, Paul Murphy, Sean Platton, Anne Riddell, Pratima Chowdary, Will Lester

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies

    Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies حسب Pratima Chowdary, Margareta Holmström, Johnny Mahlangu, Margaret C. Ozelo, Ingrid Pabinger, John Pasi, Margaret V. Ragni, Amy D. Shapiro, Chris Barnowski, Stefan Lethagen

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Safety and efficacy of turoctocog alfa (NovoEight<sup>®</sup>) during surgery in patients with haemophilia A: results from the multinational guardian<sup>™</sup> clinical trials

    Safety and efficacy of turoctocog alfa (NovoEight<sup>®</sup>) during surgery in patients with haemophilia A: results from the multinational guardian<sup>™</sup> clinical trials حسب Elena Santagostino, Steven R. Lentz, Mudi Misgav, B. Brand, Pratima Chowdary, Aleksander Savic, Yurdanur Kılınç, Yehuda Amit, A. Amendola, Luigi Piero Solimeno, Trine Saugstrup, Irina Matytsina

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee

    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Ex... حسب Peter W. Collins, Ri Liesner, Michael Makris, Kate Talks, Pratima Chowdary, Elizabeth Chalmers, Georgina Hall, Anne Riddell, Charles Percy, C. R. M. Hay, Daniel P. Hart

    منشور في 2018
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

    Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A حسب Barbara A. Konkle, Oleksandra Stasyshyn, Pratima Chowdary, David Bevan, Tim Mant, Midori Shima, Werner Engl, Jacqueline Dyck-Jones, Monika Fuerlinger, Lisa Patrone, Bruce M. Ewenstein, Brigitt E. Abbuehl

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Efficacy and safety of <scp>OBI</scp> ‐1, an antihaemophilic factor <scp>VIII</scp> (recombinant), porcine sequence, in subjects with acquired haemophilia A

    Efficacy and safety of <scp>OBI</scp> ‐1, an antihaemophilic factor <scp>VIII</scp> (recombinant), porcine sequence, in subjects with acquired haemophilia A حسب Rebecca Kruse‐Jarres, Jean St‐Louis, A. Greist, Amy Shapiro, Hedy Smith, Pratima Chowdary, Anja Drebes, Edward D. Gomperts, C. Bourgeois, Min Mo, Aaron Novack, Heinrich Farin, Bruce M. Ewenstein

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

    Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial حسب Pratima Chowdary, Stefan Lethagen, Ute Friedrich, B. Brand, C. R. M. Hay, F. Abdul Karim, Robert Klamroth, Paul Knoebl, Michael Laffan, Johnny Mahlangu, Wolfgang Miesbach, Jørn Dalsgaard Nielsen, Mónica Martín‐Salces, Pantep Angchaisuksiri

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

    Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort حسب John Pasi, Toshko Lissitchkov, Vasily Mamonov, Tim Mant, M.A. Timofeeva, Catherine Bagot, Pratima Chowdary, Pencho Georgiev, Liana Gercheva, Kate Madigan, Nguyễn Văn Huy, Qifeng Yu, Baisong Mei, Craig C Benson, Margaret V. Ragni

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: